Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Kozák

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Faraday Discussions|September 23, 2015
Plasma-based conversion of CO2: current status and future challengesAnnemie Bogaerts, Tomas Kozák, Koen van Laer, et al.
Leukemia & Lymphoma|October 3, 2012
Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesisFie Juhl Vojdeman, Jesper Jurlander, Mars van't Veer, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Faraday Discussions|September 23, 2015
Plasma-based conversion of CO2: current status and future challengesAnnemie Bogaerts, Tomas Kozák, Koen van Laer, et al.
Leukemia & Lymphoma|October 3, 2012
Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesisFie Juhl Vojdeman, Jesper Jurlander, Mars van't Veer, et al.
Pageof 1